AC
AIMT

Athanor Capital’s Aimmune Therapeutics AIMT Stock Holding History

Athanor Capital’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-65,000
Closed -$2.24M – 867
2020
Q3 		$2.24M Buy
+65,000
New +$1.38M 0.09% 126

Athanor Capital's AIMT Position: Q4 2020 in Review

Athanor Capital sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 65,000 shares — an estimated $2.24M sold.

Athanor Capital first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $2.24M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Athanor Capital reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Athanor Capital sold 65,000 Aimmune Therapeutics shares in Q4 2020, an estimated $2.24M.
  • Athanor Capital first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
  • Athanor Capital's Aimmune Therapeutics position peaked at $2.24M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.